Definium Therapeutics, Inc. SEC filings DFTX
Definium Therapeutics, Inc. has 504 filings in SEC EDGAR's recent list, going back to Jun 8, 2020. Its latest annual report, Form 10-K, was filed on Feb 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| D | Filing | May 5, 2025 | — |
| EFFECT | Filing | Apr 29, 2024 | — |
| CORRESP | Letter to the SEC | Apr 26, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 9, 2024 | — |
| D | Filing | Mar 18, 2024 | — |
| DFAN14A | Filing | Jun 16, 2023 | — |
| DFAN14A | Filing | Jun 15, 2023 | — |
| DFAN14A | Filing | Jun 12, 2023 | — |
| DFAN14A | Filing | Jun 9, 2023 | — |
| DFAN14A | Filing | Jun 8, 2023 | — |
| DFAN14A | Filing | Jun 7, 2023 | — |
| DFAN14A | Filing | Jun 6, 2023 | — |
| DFAN14A | Filing | Jun 5, 2023 | — |
| DFAN14A | Filing | Jun 2, 2023 | — |
| DFAN14A | Filing | Jun 1, 2023 | — |
| DFAN14A | Filing | May 31, 2023 | — |
| DFAN14A | Filing | May 30, 2023 | — |
| DFAN14A | Filing | May 25, 2023 | — |
| DFAN14A | Filing | May 24, 2023 | — |
| DFAN14A | Filing | May 15, 2023 | — |
| DFAN14A | Filing | May 5, 2023 | — |
| DEFC14A | Filing | May 3, 2023 | — |
| PRRN14A | Filing | May 2, 2023 | — |
| DEFC14A | Filing | May 1, 2023 | — |
| PRER14A | Filing | May 1, 2023 | — |
| CORRESP | Letter to the SEC | Apr 28, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 28, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 27, 2023 | — |
| DFAN14A | Filing | Apr 21, 2023 | — |
| PREC14A | Filing | Apr 20, 2023 | — |
| PREC14A | Filing | Apr 18, 2023 | — |
| EFFECT | Filing | May 16, 2022 | — |
| CORRESP | Letter to the SEC | May 12, 2022 | — |
| UPLOAD | Letter from the SEC | May 10, 2022 | — |
| CERT | Filing | Apr 26, 2021 | — |
| 8-A12B | Form 8-a12b | Apr 22, 2021 | — |
| EFFECT | Filing | Apr 12, 2021 | — |
| D | Filing | Jan 20, 2021 | — |
| D | Filing | Dec 22, 2020 | — |
| D | Filing | Nov 13, 2020 | — |
| D | Filing | Jun 8, 2020 | — |
Showing 41 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- DFTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- New York, NY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1813814
- Former names
- Mind Medicine (MindMed) Inc. (until Jan 12, 2026)
Other Medicinal Chemicals & Botanical Products companies
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
- Aurora Cannabis Inc ACB
Source: SEC EDGAR filings. This is company-reported data, not investment advice.